SCHEMBL5259551

SCHEMBL5259551

Fc1ccccc1-c1nc(Cl)c2c(n1)CN(Cc1ccccc1)CC2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.50
KDM4E B2RXH2 2/20 0.50
ALDH1A1 P00352 2/20 0.50
MAPT P10636 2/20 0.50
GLA P06280 1/20 0.50
GAA P10253 1/20 0.50
HPGD P15428 1/20 0.50
PARP1 P09874 1/20 0.47
TNKS2 Q9H2K2 1/20 0.47
PARP2 Q9UGN5 1/20 0.47
GABRA1 P14867 1/20 0.47
GABRA5 P31644 1/20 0.47
GABRA3 P34903 1/20 0.47
GABRA2 P47869 1/20 0.47
GRM2 Q14416 2/20 0.46
C5AR1 P21730 1/20 0.44
CLPP Q16740 2/20 0.44
MEN1 O00255 3/20 0.44
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22720441 0.87 KMT2A (0.49) KMT2AKDM4EALDH1A1MAPTGLA
SCHEMBL172809 0.86 C5AR1 (0.51) KMT2AKDM4EALDH1A1MAPTGLA
SCHEMBL786788 0.86 KMT2A (0.47) KMT2AKDM4EALDH1A1MAPTGLA
SCHEMBL5999914 0.85 KMT2A (0.54) KMT2AKDM4EALDH1A1MAPTGLA
SCHEMBL31095294 0.81 C5AR1 (0.60) KMT2AKDM4EALDH1A1MAPTGLA
SCHEMBL1831804 0.81 C5AR1 (0.60) KMT2AKDM4EALDH1A1MAPTGLA
SCHEMBL22720440 0.80 KMT2A (0.49) KMT2AKDM4EALDH1A1MAPTGLA
SCHEMBL5999840 0.80 KMT2A (0.56) KMT2AKDM4EALDH1A1MAPTGLA
SCHEMBL5776588 0.79 KMT2A (0.53) KMT2AKDM4EALDH1A1MAPTGLA
SCHEMBL10036330 0.79 KMT2A (0.55) KMT2AKDM4EALDH1A1MAPTGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1318814-B1 TRIAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMA (US) 2007-05-30 EP disclosed